Bombus terrestris chromosome 5, iyBomTerr1.2, whole genome shotgun sequence.
Bombus terrestris (buff-tailed bumblebee)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Bombus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342925.1.\nAssembly name: iyBomTerr1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUYY000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus terrestris Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
putative sodium-coupled neutral amino acid transporter 11
mitogen-activated protein kinase kinase kinase 7
protein phosphatase inhibitor 2, transcript variant X1
protein phosphatase inhibitor 2 isoform X1
protein phosphatase inhibitor 2, transcript variant X2
protein phosphatase inhibitor 2 isoform X2
charged multivesicular body protein 1b, transcript variant X3
charged multivesicular body protein 1b, transcript variant X4
charged multivesicular body protein 1b, transcript variant X5
charged multivesicular body protein 1b, transcript variant X1
charged multivesicular body protein 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
general odorant-binding protein 71, transcript variant X2
general odorant-binding protein 71, transcript variant X1
general odorant-binding protein 71 isoform X2
general odorant-binding protein 71 isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma
uncharacterized LOC105665783, transcript variant X1
uncharacterized LOC105665783, transcript variant X3
uncharacterized LOC105665783, transcript variant X2
F-actin-capping protein subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
F-actin-capping protein subunit beta, transcript variant X1
F-actin-capping protein subunit beta isoform X1
eukaryotic translation initiation factor 5A, transcript variant X1
eukaryotic translation initiation factor 5A, transcript variant X2
eukaryotic translation initiation factor 5A, transcript variant X3
eukaryotic translation initiation factor 5A
uroporphyrinogen decarboxylase, transcript variant X1
uroporphyrinogen decarboxylase, transcript variant X2
uroporphyrinogen decarboxylase isoform X2
uroporphyrinogen decarboxylase isoform X1
FACT complex subunit Ssrp1, transcript variant X2
FACT complex subunit Ssrp1, transcript variant X1
probable 26S proteasome non-ATPase regulatory subunit 3, transcript variant X1
probable 26S proteasome non-ATPase regulatory subunit 3, transcript variant X3
probable 26S proteasome non-ATPase regulatory subunit 3, transcript variant X2
probable 26S proteasome non-ATPase regulatory subunit 3
growth arrest-specific protein 1, transcript variant X2
growth arrest-specific protein 1, transcript variant X1
zinc finger protein Xfin-like, transcript variant X2
zinc finger protein Xfin-like, transcript variant X3
zinc finger protein Xfin-like, transcript variant X1
zinc finger protein Xfin-like, transcript variant X4
zinc finger protein Xfin-like isoform X2
zinc finger protein Xfin-like isoform X3
zinc finger protein Xfin-like isoform X1
zinc finger protein Xfin-like isoform X4
tight junction protein ZO-1, transcript variant X6
tight junction protein ZO-1, transcript variant X3
tight junction protein ZO-1, transcript variant X4
tight junction protein ZO-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X1
tight junction protein ZO-1, transcript variant X2
tight junction protein ZO-1, transcript variant X5
tight junction protein ZO-1, transcript variant X8
mitochondrial glutamate carrier 1, transcript variant X1
mitochondrial glutamate carrier 1, transcript variant X2
mitochondrial glutamate carrier 1, transcript variant X4
mitochondrial glutamate carrier 1, transcript variant X3
mitochondrial glutamate carrier 1 isoform X1
mitochondrial glutamate carrier 1 isoform X2
uncharacterized protein CG4449, transcript variant X3
uncharacterized protein CG4449, transcript variant X4
uncharacterized protein CG4449, transcript variant X1
uncharacterized protein CG4449, transcript variant X2
uncharacterized protein CG4449 isoform X1
uncharacterized protein CG4449 isoform X2
uncharacterized protein CG4449 isoform X3
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X2
tRNA modification GTPase GTPBP3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
TP53-regulated inhibitor of apoptosis 1, transcript variant X2
TP53-regulated inhibitor of apoptosis 1, transcript variant X1
TP53-regulated inhibitor of apoptosis 1 isoform X2
TP53-regulated inhibitor of apoptosis 1 isoform X1
7-methylguanosine phosphate-specific 5'-nucleotidase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC100651366, transcript variant X1
uncharacterized LOC100651366, transcript variant X2
eukaryotic translation initiation factor 3 subunit J
uncharacterized LOC100650398, transcript variant X1
uncharacterized LOC100650398, transcript variant X3
uncharacterized LOC100650398, transcript variant X2
uncharacterized protein LOC100650398 isoform X2
uncharacterized protein LOC100650398 isoform X3
uncharacterized protein LOC100650398 isoform X1
transmembrane ascorbate-dependent reductase CYB561, transcript variant X2
transmembrane ascorbate-dependent reductase CYB561, transcript variant X3
transmembrane ascorbate-dependent reductase CYB561, transcript variant X1
transmembrane ascorbate-dependent reductase CYB561 isoform X1
transmembrane ascorbate-dependent reductase CYB561 isoform X2
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X4
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X5
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X1
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X3
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, transcript variant X2
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial isoform X3
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial isoform X1
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial isoform X2
recQ-mediated genome instability protein 1, transcript variant X1
recQ-mediated genome instability protein 1, transcript variant X2
recQ-mediated genome instability protein 1 isoform X1
recQ-mediated genome instability protein 1 isoform X2
uncharacterized LOC100649727, transcript variant X1
uncharacterized LOC100649727, transcript variant X3
uncharacterized LOC100649727, transcript variant X5
uncharacterized LOC100649727, transcript variant X6
uncharacterized LOC100649727, transcript variant X7
uncharacterized LOC100649727, transcript variant X4
uncharacterized LOC100649727, transcript variant X2
uncharacterized LOC100649727, transcript variant X10
uncharacterized LOC100649727, transcript variant X11
uncharacterized LOC100649727, transcript variant X12
uncharacterized LOC100649727, transcript variant X13
uncharacterized LOC100649727, transcript variant X14
uncharacterized LOC100649727, transcript variant X15
uncharacterized LOC100649727, transcript variant X9
uncharacterized LOC100649727, transcript variant X8
uncharacterized protein LOC100649727 isoform X1
uncharacterized protein LOC100649727 isoform X2
uncharacterized protein LOC100649727 isoform X3
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial, transcript variant X2
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial, transcript variant X1
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial isoform X1
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial isoform X2
uncharacterized LOC100649054, transcript variant X3
uncharacterized LOC100649054, transcript variant X1
uncharacterized LOC100649054, transcript variant X2
uncharacterized protein LOC100649054 isoform X1
uncharacterized protein LOC100649054 isoform X2
uncharacterized LOC100643402, transcript variant X1
uncharacterized LOC100643402, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X2
transcription initiation factor IIA subunit 1, transcript variant X2
transcription initiation factor IIA subunit 1, transcript variant X1
transcription initiation factor IIA subunit 1 isoform X2
transcription initiation factor IIA subunit 1 isoform X1
peroxisomal membrane protein PEX13, transcript variant X3
peroxisomal membrane protein PEX13, transcript variant X4
peroxisomal membrane protein PEX13, transcript variant X2
peroxisomal membrane protein PEX13, transcript variant X1
SR-related and CTD-associated factor 4, transcript variant X2
SR-related and CTD-associated factor 4, transcript variant X3
SR-related and CTD-associated factor 4, transcript variant X4
SR-related and CTD-associated factor 4, transcript variant X1
proteasome assembly chaperone 2, transcript variant X3
proteasome assembly chaperone 2, transcript variant X2
proteasome assembly chaperone 2, transcript variant X1
translocon-associated protein subunit delta
pleckstrin homology domain-containing family J member 1
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X1
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X2
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X3
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X4
probable E3 ubiquitin-protein ligase MGRN1, transcript variant X5
probable E3 ubiquitin-protein ligase MGRN1 isoform X1
probable E3 ubiquitin-protein ligase MGRN1 isoform X2
probable E3 ubiquitin-protein ligase MGRN1 isoform X3
probable E3 ubiquitin-protein ligase MGRN1 isoform X4
mediator of RNA polymerase II transcription subunit 9
trafficking protein particle complex subunit 8, transcript variant X2
trafficking protein particle complex subunit 8, transcript variant X1
trafficking protein particle complex subunit 8 isoform X1
trafficking protein particle complex subunit 8 isoform X2
dynein axonemal light chain 4, transcript variant X3
dynein axonemal light chain 4, transcript variant X1
dynein axonemal light chain 4, transcript variant X2
dynein axonemal light chain 4 isoform X1
dynein axonemal light chain 4 isoform X2
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X3
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X6
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X2
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X7
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X5
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X2
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X4
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X3
WD repeat domain-containing protein 83, transcript variant X2
WD repeat domain-containing protein 83, transcript variant X1
WD repeat domain-containing protein 83 isoform X1
WD repeat domain-containing protein 83 isoform X2
very low-density lipoprotein receptor, transcript variant X1
very low-density lipoprotein receptor, transcript variant X2
very low-density lipoprotein receptor, transcript variant X5
very low-density lipoprotein receptor, transcript variant X3
very low-density lipoprotein receptor, transcript variant X6
very low-density lipoprotein receptor, transcript variant X4
very low-density lipoprotein receptor, transcript variant X8
very low-density lipoprotein receptor, transcript variant X7
very low-density lipoprotein receptor isoform X1
very low-density lipoprotein receptor isoform X2
very low-density lipoprotein receptor isoform X5
very low-density lipoprotein receptor isoform X3
very low-density lipoprotein receptor isoform X8
low-density lipoprotein receptor isoform X6
very low-density lipoprotein receptor isoform X4
very low-density lipoprotein receptor isoform X7
ribosome production factor 2 homolog, transcript variant X3
ribosome production factor 2 homolog, transcript variant X2
ribosome production factor 2 homolog, transcript variant X1
ribosome production factor 2 homolog isoform X1
ribosome production factor 2 homolog isoform X2
probable cysteine--tRNA ligase, mitochondrial
RNA polymerase II-associated protein 3, transcript variant X2
RNA polymerase II-associated protein 3, transcript variant X4
RNA polymerase II-associated protein 3, transcript variant X5
RNA polymerase II-associated protein 3, transcript variant X3
RNA polymerase II-associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
regulator of microtubule dynamics protein 1-like, transcript variant X4
regulator of microtubule dynamics protein 1-like, transcript variant X1
regulator of microtubule dynamics protein 1-like, transcript variant X3
regulator of microtubule dynamics protein 1-like, transcript variant X2
regulator of microtubule dynamics protein 1-like
ribonuclease P/MRP protein subunit POP5-like
FGGY carbohydrate kinase domain-containing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
regulator of microtubule dynamics protein 1, transcript variant X4
regulator of microtubule dynamics protein 1, transcript variant X3
regulator of microtubule dynamics protein 1, transcript variant X2
regulator of microtubule dynamics protein 1, transcript variant X1
regulator of microtubule dynamics protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 113 samples with support for all annotated introns
retinol dehydrogenase 13, transcript variant X3
retinol dehydrogenase 13, transcript variant X1
retinol dehydrogenase 13, transcript variant X2
uncharacterized LOC100648772, transcript variant X3
uncharacterized LOC100648772, transcript variant X1
uncharacterized protein LOC100648772 isoform X1
uncharacterized LOC100648772, transcript variant X2
uncharacterized protein LOC100648772 isoform X2
FGGY carbohydrate kinase domain-containing protein, transcript variant X1
FGGY carbohydrate kinase domain-containing protein, transcript variant X2
FGGY carbohydrate kinase domain-containing protein isoform X1
FGGY carbohydrate kinase domain-containing protein isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ribonuclease P/MRP protein subunit POP5-like
uncharacterized LOC100642565, transcript variant X3
uncharacterized protein LOC100642565 isoform X3
uncharacterized LOC100642565, transcript variant X7
uncharacterized LOC100642565, transcript variant X6
uncharacterized LOC100642565, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
uncharacterized LOC100642565, transcript variant X8
uncharacterized LOC100642565, transcript variant X1
uncharacterized protein LOC100642565 isoform X1
uncharacterized protein LOC100642565 isoform X6
uncharacterized protein LOC100642565 isoform X7
uncharacterized LOC100642565, transcript variant X2
uncharacterized protein LOC100642565 isoform X2
uncharacterized LOC100642565, transcript variant X4
uncharacterized protein LOC100642565 isoform X4
uncharacterized LOC100642565, transcript variant X5
uncharacterized protein LOC100642565 isoform X5
uncharacterized LOC100645832, transcript variant X1
uncharacterized LOC100645832, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100645832 isoform X1
uncharacterized protein LOC100645832 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC100645487, transcript variant X2
uncharacterized LOC100645487, transcript variant X1
uncharacterized protein LOC100645487 isoform X2
uncharacterized protein LOC100645487 isoform X1
A-kinase anchor protein 10, mitochondrial, transcript variant X3
A-kinase anchor protein 10, mitochondrial, transcript variant X1
A-kinase anchor protein 10, mitochondrial isoform X1
A-kinase anchor protein 10, mitochondrial, transcript variant X2
A-kinase anchor protein 10, mitochondrial isoform X2
A-kinase anchor protein 10, mitochondrial isoform X3
putative 28S ribosomal protein S5, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 179, transcript variant X2
transmembrane protein 179, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dynein regulatory complex subunit 7
protein distal antenna, transcript variant X1
protein distal antenna, transcript variant X2
dynein regulatory complex subunit 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
dynein regulatory complex subunit 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
dynein regulatory complex subunit 7 isoform X1
dynein regulatory complex subunit 7 isoform X2
uncharacterized LOC125385150, transcript variant X1
uncharacterized LOC125385150, transcript variant X2
FERM domain-containing protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 114 samples with support for all annotated introns
FERM domain-containing protein 8 isoform X1
FERM domain-containing protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
FERM domain-containing protein 8 isoform X2
eukaryotic initiation factor 4A-III, transcript variant X5
eukaryotic initiation factor 4A-III, transcript variant X4
eukaryotic initiation factor 4A-III, transcript variant X3
eukaryotic initiation factor 4A-III, transcript variant X2
eukaryotic initiation factor 4A-III, transcript variant X1
uncharacterized LOC100643691, transcript variant X2
uncharacterized LOC100643691, transcript variant X1
uncharacterized protein LOC100643691 isoform X2
uncharacterized protein LOC100643691 isoform X1
uncharacterized LOC100643691, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
uncharacterized LOC100643691, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
uncharacterized protein LOC100643691 isoform X3
metastasis-associated protein MTA2, transcript variant X1
metastasis-associated protein MTA2, transcript variant X4
metastasis-associated protein MTA2, transcript variant X2
metastasis-associated protein MTA2, transcript variant X3
metastasis-associated protein MTA3 isoform X1
metastasis-associated protein MTA2 isoform X2
metastasis-associated protein MTA3 isoform X3
metastasis-associated protein MTA3 isoform X4
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01296
splicing factor 3B subunit 2, transcript variant X2
splicing factor 3B subunit 2, transcript variant X1
GPI ethanolamine phosphate transferase 1, transcript variant X2
GPI ethanolamine phosphate transferase 1, transcript variant X1
GPI ethanolamine phosphate transferase 1, transcript variant X4
GPI ethanolamine phosphate transferase 1, transcript variant X3
GPI ethanolamine phosphate transferase 1, transcript variant X5
GPI ethanolamine phosphate transferase 1, transcript variant X7
GPI ethanolamine phosphate transferase 1, transcript variant X6
GPI ethanolamine phosphate transferase 1 isoform X2
GPI ethanolamine phosphate transferase 1 isoform X1
GPI ethanolamine phosphate transferase 1 isoform X4
GPI ethanolamine phosphate transferase 1 isoform X3
GPI ethanolamine phosphate transferase 1 isoform X5
GPI ethanolamine phosphate transferase 1 isoform X6
GPI ethanolamine phosphate transferase 1 isoform X7
probable glucosamine 6-phosphate N-acetyltransferase
uncharacterized LOC100642326, transcript variant X1
uncharacterized protein LOC100642326 isoform X1
uncharacterized LOC100642326, transcript variant X2
uncharacterized protein LOC100642326 isoform X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X4
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X3
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X1
bromodomain adjacent to zinc finger domain protein 1A isoform X2
bromodomain adjacent to zinc finger domain protein 1A isoform X4
bromodomain adjacent to zinc finger domain protein 1A isoform X3
bromodomain adjacent to zinc finger domain protein 1A isoform X1
probable DNA-directed RNA polymerase III subunit RPC6
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial
uncharacterized protein PF3D7_1120600, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
uncharacterized protein PF3D7_1120600, transcript variant X1
uncharacterized protein PF3D7_1120600, transcript variant X2
uncharacterized protein PF3D7_1120600 isoform X1
uncharacterized protein PF3D7_1120600 isoform X2
uncharacterized protein PF3D7_1120600 isoform X3
repetitive organellar protein, transcript variant X2
repetitive organellar protein, transcript variant X1
DNA replication licensing factor Mcm5, transcript variant X1
DNA replication licensing factor Mcm5, transcript variant X2
rho GTPase-activating protein gacF, transcript variant X1
rho GTPase-activating protein gacF, transcript variant X4
rho GTPase-activating protein gacF, transcript variant X2
rho GTPase-activating protein gacF, transcript variant X3
uncharacterized protein LOC100650641 isoform X1
uncharacterized protein LOC100650641 isoform X4
rho GTPase-activating protein gacF isoform X2
uncharacterized protein LOC100650641 isoform X3
E3 ubiquitin-protein ligase synoviolin A, transcript variant X1
E3 ubiquitin-protein ligase synoviolin A, transcript variant X3
E3 ubiquitin-protein ligase synoviolin A, transcript variant X2
E3 ubiquitin-protein ligase synoviolin A
serine/threonine-protein phosphatase 4 regulatory subunit 3
cilia- and flagella-associated protein 36
LHFPL tetraspan subfamily member 5 protein
uncharacterized LOC100649410, transcript variant X2
uncharacterized LOC100649410, transcript variant X5
uncharacterized LOC100649410, transcript variant X1
uncharacterized LOC100649410, transcript variant X4
uncharacterized LOC100649410, transcript variant X3
uncharacterized protein LOC100649410 isoform X2
uncharacterized protein LOC100649410 isoform X5
uncharacterized protein LOC100649410 isoform X1
uncharacterized protein LOC100649410 isoform X4
uncharacterized protein LOC100649410 isoform X3
replication protein A 70 kDa DNA-binding subunit, transcript variant X1
replication protein A 70 kDa DNA-binding subunit, transcript variant X2
replication protein A 70 kDa DNA-binding subunit isoform X1
replication protein A 70 kDa DNA-binding subunit isoform X2
replication protein A 70 kDa DNA-binding subunit, transcript variant X3
replication protein A 70 kDa DNA-binding subunit isoform X3
complement component 1 Q subcomponent-binding protein, mitochondrial
ras-related protein Rab-43, transcript variant X1
ras-related protein Rab-43, transcript variant X2
hydroxymethylglutaryl-CoA synthase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001308307.1
annotated by transcript or proteomic data
The RefSeq transcript has 2 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
putative uncharacterized protein DDB_G0289263, transcript variant X2
putative uncharacterized protein DDB_G0289263, transcript variant X1
putative uncharacterized protein DDB_G0289263, transcript variant X4
putative uncharacterized protein DDB_G0289263, transcript variant X5
putative uncharacterized protein DDB_G0289263, transcript variant X6
putative uncharacterized protein DDB_G0289263, transcript variant X3
putative uncharacterized protein DDB_G0289263, transcript variant X7
putative uncharacterized protein DDB_G0289263, transcript variant X8
uncharacterized protein LOC100651638 isoform X1
uncharacterized protein LOC100651638 isoform X2
putative uncharacterized protein DDB_G0289263 isoform X3
RRP15-like protein, transcript variant X3
RRP15-like protein, transcript variant X2
RRP15-like protein, transcript variant X1
ADP-ribosylation factor-binding protein GGA3, transcript variant X2
ADP-ribosylation factor-binding protein GGA3 isoform X2
ADP-ribosylation factor-binding protein GGA3, transcript variant X1
ADP-ribosylation factor-binding protein GGA3 isoform X1
target of rapamycin complex subunit lst8
SAP30-binding protein, transcript variant X3
SAP30-binding protein, transcript variant X1
SAP30-binding protein, transcript variant X2
SAP30-binding protein, transcript variant X4
SAP30-binding protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
SAP30-binding protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
SAP30-binding protein, transcript variant X6
SAP30-binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 155 samples with support for all annotated introns
serine--tRNA ligase, cytoplasmic, transcript variant X3
serine--tRNA ligase, cytoplasmic, transcript variant X1
serine--tRNA ligase, cytoplasmic isoform X1
serine--tRNA ligase, cytoplasmic, transcript variant X2
serine--tRNA ligase, cytoplasmic isoform X2
serine--tRNA ligase, cytoplasmic isoform X3
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
39S ribosomal protein L17, mitochondrial
E3 ubiquitin-protein ligase RNF34, transcript variant X1
E3 ubiquitin-protein ligase RNF34, transcript variant X2
uncharacterized LOC105665771, transcript variant X2
uncharacterized LOC105665771, transcript variant X1
uncharacterized protein LOC105665771 isoform X1
uncharacterized protein LOC105665771 isoform X2
iroquois-class homeodomain protein IRX-6, transcript variant X2
iroquois-class homeodomain protein IRX-6, transcript variant X1
iroquois-class homeodomain protein IRX-6 isoform X2
iroquois-class homeodomain protein IRX-6 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X2
cytoplasmic tRNA 2-thiolation protein 2, transcript variant X1
39S ribosomal protein L40, mitochondrial
ERAD-associated E3 ubiquitin-protein ligase HRD1B, transcript variant X1
ERAD-associated E3 ubiquitin-protein ligase HRD1B, transcript variant X2
ERAD-associated E3 ubiquitin-protein ligase HRD1B, transcript variant X4
ERAD-associated E3 ubiquitin-protein ligase HRD1B, transcript variant X3
ERAD-associated E3 ubiquitin-protein ligase HRD1B isoform X1
ERAD-associated E3 ubiquitin-protein ligase HRD1B isoform X2
diphthine methyl ester synthase, transcript variant X2
diphthine methyl ester synthase, transcript variant X1
diphthine methyl ester synthase isoform X2
diphthine methyl ester synthase isoform X1
essential MCU regulator, mitochondrial, transcript variant X4
essential MCU regulator, mitochondrial, transcript variant X5
essential MCU regulator, mitochondrial, transcript variant X3
essential MCU regulator, mitochondrial, transcript variant X1
essential MCU regulator, mitochondrial, transcript variant X2
protein flightless-1, transcript variant X1
protein flightless-1, transcript variant X2
protein flightless-1, transcript variant X3
protein flightless-1, transcript variant X4
protein flightless-1, transcript variant X5
mitochondrial import receptor subunit TOM22 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC125385095, transcript variant X2
uncharacterized LOC125385095, transcript variant X1
elongation of very long chain fatty acids protein 1
cysteine sulfinic acid decarboxylase, transcript variant X2
cysteine sulfinic acid decarboxylase, transcript variant X1
cysteine sulfinic acid decarboxylase isoform X1
cysteine sulfinic acid decarboxylase isoform X2
protein UXT homolog, transcript variant X3
protein UXT homolog, transcript variant X2
protein UXT homolog, transcript variant X4
protein UXT homolog, transcript variant X1
doublesex- and mab-3-related transcription factor A2, transcript variant X3
doublesex- and mab-3-related transcription factor A2, transcript variant X1
doublesex- and mab-3-related transcription factor A2, transcript variant X4
doublesex- and mab-3-related transcription factor A2, transcript variant X2
doublesex- and mab-3-related transcription factor A2 isoform X2
doublesex- and mab-3-related transcription factor A2 isoform X1
doublesex- and mab-3-related transcription factor A2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor A2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor A2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor A2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor A2, transcript variant X5
doublesex- and mab-3-related transcription factor A2 isoform X3
uncharacterized LOC110119327, transcript variant X4
uncharacterized LOC110119327, transcript variant X3
uncharacterized LOC110119327, transcript variant X1
uncharacterized LOC110119327, transcript variant X2
homeobox protein prospero, transcript variant X1
homeobox protein prospero, transcript variant X2
uncharacterized LOC105665769, transcript variant X2
uncharacterized LOC105665769, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X3
C-1-tetrahydrofolate synthase, cytoplasmic isoform X3
probable methyltransferase-like protein 15 homolog
dnaJ homolog subfamily C member 13, transcript variant X2
dnaJ homolog subfamily C member 13, transcript variant X1
dnaJ homolog subfamily C member 13 isoform X2
dnaJ homolog subfamily C member 13 isoform X1
angiogenic factor with G patch and FHA domains 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
angiogenic factor with G patch and FHA domains 1, transcript variant X5
angiogenic factor with G patch and FHA domains 1, transcript variant X2
angiogenic factor with G patch and FHA domains 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
angiogenic factor with G patch and FHA domains 1, transcript variant X1
angiogenic factor with G patch and FHA domains 1, transcript variant X4
angiogenic factor with G patch and FHA domains 1, transcript variant X3
angiogenic factor with G patch and FHA domains 1
uncharacterized LOC100650807, transcript variant X2
uncharacterized LOC100650807, transcript variant X1
uncharacterized LOC100650807, transcript variant X4
uncharacterized LOC100650807, transcript variant X3
uncharacterized protein LOC100650807 isoform X2
uncharacterized protein LOC100650807 isoform X1
uncharacterized protein LOC100650807 isoform X3
uncharacterized LOC100650807, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC100650807 isoform X4
uncharacterized LOC100643446, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC100643446, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP62
protein yippee-like 1, transcript variant X1
protein yippee-like 1, transcript variant X2
uncharacterized LOC100642516, transcript variant X1
zinc finger protein 530, transcript variant X1
zinc finger protein 530, transcript variant X2
uncharacterized LOC100642516, transcript variant X8
uncharacterized LOC100642516, transcript variant X3
uncharacterized LOC100642516, transcript variant X6
uncharacterized LOC100642516, transcript variant X2
uncharacterized LOC100642516, transcript variant X5
uncharacterized LOC100642516, transcript variant X4
uncharacterized LOC100642516, transcript variant X7
uncharacterized protein LOC100642516 isoform X1
uncharacterized protein LOC100642516 isoform X2
SPRY domain-containing SOCS box protein 3
cytochrome c oxidase subunit 5A, mitochondrial
DNA-binding protein Ewg, transcript variant X2
DNA-binding protein Ewg, transcript variant X4
DNA-binding protein Ewg, transcript variant X5
DNA-binding protein Ewg, transcript variant X1
DNA-binding protein Ewg, transcript variant X3
DNA-binding protein Ewg, transcript variant X6
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X2
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X1
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X2
uncharacterized LOC125385065, transcript variant X3
uncharacterized LOC125385065, transcript variant X2
uncharacterized LOC125385065, transcript variant X1
scm-like with four MBT domains protein 1, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X1
scm-like with four MBT domains protein 1 isoform X2
scm-like with four MBT domains protein 1 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X6
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein rolling stone, transcript variant X1
protein rolling stone, transcript variant X2
zinc finger and BTB domain-containing protein 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
F-box/WD repeat-containing protein 9, transcript variant X2
F-box/WD repeat-containing protein 9, transcript variant X1
solute carrier family 52, riboflavin transporter, member 3-A-like
solute carrier family 52, riboflavin transporter, member 3-A, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-A, transcript variant X1
solute carrier family 52, riboflavin transporter, member 3-A
uncharacterized LOC100649925, transcript variant X2
uncharacterized LOC100649925, transcript variant X1
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
bromodomain-containing protein 7, transcript variant X4
bromodomain-containing protein 7, transcript variant X5
bromodomain-containing protein 7, transcript variant X3
bromodomain-containing protein 7, transcript variant X1
bromodomain-containing protein 7, transcript variant X2
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X2
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4, transcript variant X7
solute carrier family 12 member 4, transcript variant X6
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4 isoform X4
PRKC apoptosis WT1 regulator protein, transcript variant X4
PRKC apoptosis WT1 regulator protein, transcript variant X1
PRKC apoptosis WT1 regulator protein, transcript variant X6
PRKC apoptosis WT1 regulator protein, transcript variant X2
PRKC apoptosis WT1 regulator protein, transcript variant X5
PRKC apoptosis WT1 regulator protein, transcript variant X3
PRKC apoptosis WT1 regulator protein isoform X1
PRKC apoptosis WT1 regulator protein isoform X4
PRKC apoptosis WT1 regulator protein isoform X2
PRKC apoptosis WT1 regulator protein isoform X3
dual specificity protein phosphatase 10, transcript variant X2
dual specificity protein phosphatase 10, transcript variant X1
dual specificity protein phosphatase 10, transcript variant X3
dual specificity protein phosphatase 10, transcript variant X4
dual specificity protein phosphatase 10, transcript variant X5
dual specificity protein phosphatase 10 isoform X2
dual specificity protein phosphatase 10 isoform X1
dual specificity protein phosphatase 10 isoform X3
protein unc-79 homolog, transcript variant X2
protein unc-79 homolog, transcript variant X1
protein unc-79 homolog, transcript variant X7
protein unc-79 homolog, transcript variant X10
protein unc-79 homolog, transcript variant X8
protein unc-79 homolog, transcript variant X4
protein unc-79 homolog, transcript variant X3
protein unc-79 homolog, transcript variant X5
protein unc-79 homolog, transcript variant X9
protein unc-79 homolog, transcript variant X6
protein unc-79 homolog, transcript variant X11
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14 isoform X1
tyrosine-protein phosphatase non-receptor type 14, transcript variant X4
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X3
tyrosine-protein phosphatase non-receptor type 14 isoform X2
uncharacterized LOC100648821, transcript variant X2
uncharacterized LOC100648821, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 3
uncharacterized LOC100648162, transcript variant X1
uncharacterized LOC100648162, transcript variant X2
uncharacterized protein LOC100648162 isoform X2
uncharacterized protein LOC100648162 isoform X1
monocarboxylate transporter 12-B, transcript variant X1
monocarboxylate transporter 12-B, transcript variant X3
monocarboxylate transporter 12-B, transcript variant X4
monocarboxylate transporter 12-B, transcript variant X2
monocarboxylate transporter 12-B, transcript variant X6
monocarboxylate transporter 12-B, transcript variant X5
monocarboxylate transporter 12-B isoform X1
monocarboxylate transporter 12-B isoform X3
monocarboxylate transporter 12-B isoform X2
monocarboxylate transporter 12-B isoform X4
monocarboxylate transporter 12-B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
monocarboxylate transporter 12-B, transcript variant X7
monocarboxylate transporter 12-B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC100647965 isoform X5
uncharacterized protein LOC100647965 isoform X6
uncharacterized protein LOC100647965 isoform X7
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3, transcript variant X7
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3, transcript variant X6
monocarboxylate transporter 3, transcript variant X8
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3, transcript variant X9
monocarboxylate transporter 3 isoform X2
monocarboxylate transporter 3 isoform X5
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X4
monocarboxylate transporter 3 isoform X3
uncharacterized protein LOC100647772 isoform X6
uncharacterized protein LOC100647772 isoform X7
heat shock factor 2-binding protein, transcript variant X2
heat shock factor 2-binding protein, transcript variant X1
delta(14)-sterol reductase LBR, transcript variant X1
delta(14)-sterol reductase LBR, transcript variant X2
delta(14)-sterol reductase LBR isoform X1
delta(14)-sterol reductase LBR isoform X2
proteasome assembly chaperone 1, transcript variant X2
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1 isoform X1
proteasome assembly chaperone 1 isoform X2
ribosomal protein S6 kinase alpha-2, transcript variant X1
ribosomal protein S6 kinase alpha-2, transcript variant X2
ribosomal protein S6 kinase 2 beta isoform X1
ribosomal protein S6 kinase alpha-2 isoform X2
guanylate kinase, transcript variant X13
guanylate kinase, transcript variant X12
guanylate kinase, transcript variant X11
guanylate kinase, transcript variant X10
uncharacterized LOC100647061, transcript variant X9
uncharacterized LOC100647061, transcript variant X8
uncharacterized LOC100647061, transcript variant X3
uncharacterized LOC100647061, transcript variant X4
uncharacterized LOC100647061, transcript variant X7
uncharacterized LOC100647061, transcript variant X6
uncharacterized LOC100647061, transcript variant X1
uncharacterized LOC100647061, transcript variant X2
uncharacterized LOC100647061, transcript variant X5
uncharacterized LOC100647061, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G-protein coupled receptor dmsr-1, transcript variant X1
G-protein coupled receptor dmsr-1, transcript variant X2
G-protein coupled receptor dmsr-1, transcript variant X4
G-protein coupled receptor dmsr-1, transcript variant X3
Bardet-Biedl syndrome 4 protein, transcript variant X3
Bardet-Biedl syndrome 4 protein, transcript variant X2
Bardet-Biedl syndrome 4 protein, transcript variant X1
Bardet-Biedl syndrome 4 protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
Bardet-Biedl syndrome 4 protein isoform X4
Bardet-Biedl syndrome 4 protein isoform X2
Bardet-Biedl syndrome 4 protein isoform X1
Bardet-Biedl syndrome 4 protein isoform X3
solute carrier family 35 member F5, transcript variant X1
solute carrier family 35 member F5 isoform X1
solute carrier family 35 member F5, transcript variant X2
solute carrier family 35 member F5 isoform X2
uncharacterized LOC100649728, transcript variant X2
uncharacterized LOC100649728, transcript variant X1
uncharacterized LOC100649728, transcript variant X3
uncharacterized protein LOC100649728 isoform X1
uncharacterized protein LOC100649728 isoform X3
uncharacterized protein LOC100649728 isoform X2
inosine-5'-monophosphate dehydrogenase 1b
eukaryotic translation elongation factor 1 epsilon-1
Bardet-Biedl syndrome 4 protein, transcript variant X5
mitochondrial uncoupling protein Bmcp, transcript variant X2
mitochondrial uncoupling protein Bmcp, transcript variant X1
solute carrier family 66 member 2, transcript variant X2
solute carrier family 66 member 2, transcript variant X1
solute carrier family 66 member 2 isoform X2
solute carrier family 66 member 2 isoform X1
uncharacterized LOC100649620, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
uncharacterized LOC100649620, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized protein LOC100649620 isoform X1
uncharacterized protein LOC100649620 isoform X2
DNA repair protein RAD51 homolog A, transcript variant X1
DNA repair protein RAD51 homolog A, transcript variant X2
DNA polymerase alpha subunit B, transcript variant X1
DNA polymerase alpha subunit B isoform X1
DNA polymerase alpha subunit B, transcript variant X3
DNA polymerase alpha subunit B isoform X3
DNA polymerase alpha subunit B, transcript variant X2
DNA polymerase alpha subunit B isoform X2
DNA polymerase alpha subunit B, transcript variant X4
DNA polymerase alpha subunit B isoform X4
steroid hormone receptor ERR1, transcript variant X2
steroid hormone receptor ERR1 isoform X2
steroid hormone receptor ERR1, transcript variant X1
steroid hormone receptor ERR1, transcript variant X4
steroid hormone receptor ERR1, transcript variant X3
steroid hormone receptor ERR1, transcript variant X5
steroid hormone receptor ERR1 isoform X1
steroid hormone receptor ERR1 isoform X4
steroid hormone receptor ERR1 isoform X3
steroid hormone receptor ERR1 isoform X5
uncharacterized LOC100644290, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC100644290, transcript variant X4
uncharacterized LOC100644290, transcript variant X2
uncharacterized LOC100644290, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
glucose dehydrogenase [FAD, quinone]-like isoform X1
glucose dehydrogenase [FAD, quinone]-like, transcript variant X4
glucose dehydrogenase [FAD, quinone]-like, transcript variant X5
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like isoform X2
synaptogenesis protein syg-2, transcript variant X4
synaptogenesis protein syg-2, transcript variant X5
synaptogenesis protein syg-2, transcript variant X3
synaptogenesis protein syg-2, transcript variant X2
synaptogenesis protein syg-2, transcript variant X1
neural cell adhesion molecule 2 isoform X3
neural cell adhesion molecule 2 isoform X1
neural cell adhesion molecule 2 isoform X2
synaptogenesis protein syg-2, transcript variant X6
synaptogenesis protein syg-2, transcript variant X7
uncharacterized LOC110119283, transcript variant X2
uncharacterized LOC110119283, transcript variant X1
translin-associated protein X, transcript variant X3
translin-associated protein X, transcript variant X2
translin-associated protein X, transcript variant X1
translin-associated protein X isoform X1
translin-associated protein X isoform X2
aprataxin and PNK-like factor, transcript variant X3
aprataxin and PNK-like factor, transcript variant X2
aprataxin and PNK-like factor, transcript variant X1
aprataxin and PNK-like factor isoform X3
aprataxin and PNK-like factor isoform X2
aprataxin and PNK-like factor isoform X1
WD repeat-containing protein 20, transcript variant X1
WD repeat-containing protein 20, transcript variant X2
WD repeat-containing protein 20 isoform X2
WD repeat-containing protein 20 isoform X1
WD repeat-containing protein 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 111 samples with support for all annotated introns
WD repeat-containing protein 20 isoform X3
U3 small nucleolar RNA-associated protein 25 homolog
uncharacterized LOC105665757, transcript variant X1
uncharacterized LOC105665757, transcript variant X3
uncharacterized LOC105665757, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 192, transcript variant X1
transmembrane protein 192, transcript variant X3
transmembrane protein 192, transcript variant X4
transmembrane protein 192, transcript variant X2
uncharacterized LOC100642958, transcript variant X1
uncharacterized LOC100642958, transcript variant X2
uncharacterized protein LOC100642958 isoform X1
uncharacterized protein LOC100642958 isoform X2
replication stress response regulator SDE2
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial-like
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
uncharacterized LOC105665753, transcript variant X1
uncharacterized LOC105665753, transcript variant X3
uncharacterized LOC105665753, transcript variant X4
uncharacterized LOC105665753, transcript variant X6
uncharacterized LOC105665753, transcript variant X7
uncharacterized LOC105665753, transcript variant X5
uncharacterized LOC105665753, transcript variant X2
uncharacterized LOC105665752, transcript variant X1
uncharacterized LOC105665752, transcript variant X2
uncharacterized protein LOC105665752 isoform X1
uncharacterized protein LOC105665752 isoform X2
conserved oligomeric Golgi complex subunit 4
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X1
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X2
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X3
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X7
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X5
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X4
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X6
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X8
broad-complex core protein isoforms 1/2/3/4/5 isoform X5
broad-complex core protein isoforms 1/2/3/4/5 isoform X7
broad-complex core protein isoforms 1/2/3/4/5 isoform X4
broad-complex core protein isoforms 1/2/3/4/5 isoform X1
broad-complex core protein isoforms 1/2/3/4/5 isoform X2
broad-complex core protein isoforms 1/2/3/4/5 isoform X3
broad-complex core protein isoforms 1/2/3/4/5 isoform X6
transcription and mRNA export factor ENY2
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X3
mitochondrial import inner membrane translocase subunit Tim21, transcript variant X4
mitochondrial import inner membrane translocase subunit Tim21
T-box transcription factor TBX20, transcript variant X2
T-box transcription factor TBX20 isoform X2
T-box transcription factor TBX20, transcript variant X1
T-box transcription factor TBX20 isoform X1
T-box protein H15, transcript variant X1
T-box protein H15, transcript variant X2
WD repeat and FYVE domain-containing protein 2
suppressor of hairless protein, transcript variant X3
suppressor of hairless protein, transcript variant X1
suppressor of hairless protein, transcript variant X2
DNA excision repair protein ERCC-5 homolog, transcript variant X1
DNA excision repair protein ERCC-5 homolog, transcript variant X4
DNA excision repair protein ERCC-5 homolog, transcript variant X2
DNA excision repair protein ERCC-5 homolog, transcript variant X3
DNA excision repair protein ERCC-5 homolog
glutathione hydrolase 1 proenzyme, transcript variant X2
glutathione hydrolase 1 proenzyme, transcript variant X1
glutathione hydrolase 1 proenzyme isoform X1
glutathione hydrolase 1 proenzyme isoform X2
inverted formin-2, transcript variant X6
inverted formin-2, transcript variant X4
inverted formin-2, transcript variant X5
inverted formin-2, transcript variant X1
inverted formin-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 127 samples with support for all annotated introns
uncharacterized protein LOC100649329 isoform X1
inverted formin-2, transcript variant X2
uncharacterized protein LOC100649329 isoform X2
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X2
uncharacterized aarF domain-containing protein kinase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized aarF domain-containing protein kinase 2
adenosine 3'-phospho 5'-phosphosulfate transporter 1
deoxynucleoside kinase, transcript variant X2
deoxynucleoside kinase, transcript variant X1
protein immune deficiency, transcript variant X2
protein immune deficiency, transcript variant X1
protein immune deficiency, transcript variant X3
protein immune deficiency, transcript variant X9
protein immune deficiency, transcript variant X5
protein immune deficiency, transcript variant X7
protein immune deficiency, transcript variant X8
protein immune deficiency, transcript variant X4
protein immune deficiency, transcript variant X6
protein immune deficiency, transcript variant X10
uncharacterized protein LOC100648975 isoform X2
uncharacterized LOC105665748, transcript variant X1
uncharacterized LOC105665748, transcript variant X2
uncharacterized protein LOC105665748 isoform X1
uncharacterized protein LOC105665748 isoform X2
protein C1orf43 homolog, transcript variant X3
protein C1orf43 homolog, transcript variant X1
protein C1orf43 homolog, transcript variant X2
uncharacterized LOC100648746, transcript variant X2
uncharacterized LOC100648746, transcript variant X1
zinc finger protein 608, transcript variant X6
zinc finger protein 608, transcript variant X5
zinc finger protein 608, transcript variant X10
zinc finger protein 608, transcript variant X13
zinc finger protein 608, transcript variant X2
zinc finger protein 608, transcript variant X7
zinc finger protein 608, transcript variant X4
zinc finger protein 608, transcript variant X3
zinc finger protein 608, transcript variant X1
zinc finger protein 608, transcript variant X12
zinc finger protein 608, transcript variant X11
zinc finger protein 608, transcript variant X9
zinc finger protein 608, transcript variant X8
ribosomal protein S5a, transcript variant X1
ribosomal protein S5a, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
uncharacterized LOC105665746, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC105665746, transcript variant X3
uncharacterized LOC105665746, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC105665746 isoform X1
uncharacterized protein LOC105665746 isoform X2
kinesin-like protein KIF2A, transcript variant X1
kinesin-like protein KIF2A, transcript variant X2
kinesin-like protein KIF2A, transcript variant X3
kinesin-like protein KIF2A, transcript variant X5
kinesin-like protein KIF2A, transcript variant X6
kinesin-like protein KIF2A, transcript variant X7
kinesin-like protein KIF2A, transcript variant X4
protein adenylyltransferase Fic, transcript variant X1
protein adenylyltransferase Fic, transcript variant X2
protein adenylyltransferase Fic isoform X2
protein adenylyltransferase Fic isoform X1
lysosomal acid phosphatase, transcript variant X2
lysosomal acid phosphatase, transcript variant X3
lysosomal acid phosphatase, transcript variant X5
lysosomal acid phosphatase, transcript variant X1
lysosomal acid phosphatase, transcript variant X4
EH domain-containing protein 3, transcript variant X2
EH domain-containing protein 3, transcript variant X1
EH domain-containing protein 3 isoform X1
EH domain-containing protein 3, transcript variant X3
EH domain-containing protein 1 isoform X2
zinc finger protein 25, transcript variant X1
zinc finger protein 25, transcript variant X2
signal recognition particle 14 kDa protein, transcript variant X1
signal recognition particle 14 kDa protein, transcript variant X2
signal recognition particle 14 kDa protein
N-alpha-acetyltransferase 40, transcript variant X1
N-alpha-acetyltransferase 40, transcript variant X2
proteasome activator complex subunit 4, transcript variant X2
proteasome activator complex subunit 4, transcript variant X1
proteasome activator complex subunit 4 isoform X1
proteasome activator complex subunit 4, transcript variant X3
proteasome activator complex subunit 4 isoform X2
N-alpha-acetyltransferase 80, transcript variant X1
N-alpha-acetyltransferase 80, transcript variant X2
mediator of RNA polymerase II transcription subunit 6, transcript variant X2
mediator of RNA polymerase II transcription subunit 6, transcript variant X3
mediator of RNA polymerase II transcription subunit 6, transcript variant X1
mediator of RNA polymerase II transcription subunit 6 isoform X1
mediator of RNA polymerase II transcription subunit 6 isoform X2
F-box only protein 11, transcript variant X2
F-box only protein 11, transcript variant X3
F-box only protein 11, transcript variant X1
SH3KBP1-binding protein 1, transcript variant X1
SH3KBP1-binding protein 1, transcript variant X2
SH3KBP1-binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 138 samples with support for all annotated introns
odorant receptor 13a, transcript variant X1
odorant receptor 13a, transcript variant X2
odorant receptor 13a, transcript variant X3
kinesin-related protein 4, transcript variant X1
kinesin-related protein 4, transcript variant X2
L-threonine ammonia-lyase, transcript variant X2
L-threonine ammonia-lyase, transcript variant X1
uncharacterized LOC100645321, transcript variant X6
uncharacterized LOC100645321, transcript variant X3
uncharacterized LOC100645321, transcript variant X1
uncharacterized LOC100645321, transcript variant X2
uncharacterized LOC100645321, transcript variant X4
uncharacterized LOC100645321, transcript variant X5
tubulin--tyrosine ligase-like protein 12
putative transferase CAF17 homolog, mitochondrial
unc-112-related protein, transcript variant X1
unc-112-related protein, transcript variant X2
testis-specific serine/threonine-protein kinase 1, transcript variant X1
testis-specific serine/threonine-protein kinase 1, transcript variant X2
testis-specific serine/threonine-protein kinase 2 isoform X2
testis-specific serine/threonine-protein kinase 1 isoform X1
zinc transporter 7, transcript variant X2
zinc transporter 7, transcript variant X1
zinc transporter 7, transcript variant X5
zinc transporter 7, transcript variant X3
zinc transporter 7, transcript variant X4
uncharacterized LOC100647259, transcript variant X2
uncharacterized LOC100647259, transcript variant X3
uncharacterized LOC100647259, transcript variant X4
uncharacterized LOC100647259, transcript variant X1
uncharacterized protein LOC100647259 isoform X2
uncharacterized protein LOC100647259 isoform X1
uncharacterized LOC125385073, transcript variant X2
uncharacterized LOC125385073, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: neuroendocrine convertase 2
myb-like protein V, transcript variant X4
myb-like protein V, transcript variant X1
myb-like protein V, transcript variant X2
myb-like protein V, transcript variant X3
protein FAM50 homolog, transcript variant X1
protein FAM50 homolog, transcript variant X2
protein enabled homolog, transcript variant X1
protein enabled homolog, transcript variant X2
probable ATP-dependent RNA helicase spindle-E, transcript variant X1
probable ATP-dependent RNA helicase spindle-E, transcript variant X2
probable ATP-dependent RNA helicase spindle-E, transcript variant X3
probable ATP-dependent RNA helicase spindle-E isoform X1
probable ATP-dependent RNA helicase spindle-E isoform X2
probable ATP-dependent RNA helicase spindle-E isoform X3
protein O-mannosyl-transferase 2, transcript variant X1
protein O-mannosyl-transferase 2, transcript variant X2
transmembrane protein 8B, transcript variant X3
transmembrane protein 8B, transcript variant X2
transmembrane protein 8B, transcript variant X1
uncharacterized LOC100646779, transcript variant X2
uncharacterized LOC100646779, transcript variant X3
uncharacterized LOC100646779, transcript variant X1
uncharacterized protein LOC100646779 isoform X2
uncharacterized protein LOC100646779 isoform X1
uncharacterized LOC100646655, transcript variant X1
uncharacterized LOC100646655, transcript variant X2
zinc finger protein 16, transcript variant X5
zinc finger protein 16, transcript variant X4
zinc finger protein 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
zinc finger protein 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
zinc finger protein 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
zinc finger protein 16, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
zinc finger protein 16, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 90 samples with support for all annotated introns
tubulin polyglutamylase TTLL5, transcript variant X4
tubulin polyglutamylase TTLL5, transcript variant X1
tubulin polyglutamylase TTLL5, transcript variant X2
tubulin polyglutamylase TTLL5, transcript variant X3
tubulin polyglutamylase TTLL5 isoform X2
tubulin polyglutamylase TTLL5 isoform X1
uncharacterized LOC100652191, transcript variant X1
uncharacterized LOC100652191, transcript variant X4
uncharacterized LOC100652191, transcript variant X3
uncharacterized LOC100652191, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
molybdopterin synthase catalytic subunit, transcript variant X1
molybdopterin synthase catalytic subunit, transcript variant X2
molybdopterin synthase catalytic subunit
RNA-binding protein Pasilla, transcript variant X1
RNA-binding protein Pasilla, transcript variant X3
RNA-binding protein Pasilla, transcript variant X2
scaffold protein salvador, transcript variant X3
scaffold protein salvador, transcript variant X2
scaffold protein salvador, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X2
uncharacterized LOC105665740, transcript variant X5
uncharacterized LOC105665740, transcript variant X4
uncharacterized LOC105665740, transcript variant X1
uncharacterized LOC105665740, transcript variant X3
uncharacterized LOC105665740, transcript variant X2
uncharacterized LOC105665740, transcript variant X6
neutral and basic amino acid transport protein rBAT, transcript variant X2
neutral and basic amino acid transport protein rBAT, transcript variant X1
neutral and basic amino acid transport protein rBAT isoform X2
neutral and basic amino acid transport protein rBAT isoform X1
sodium/calcium exchanger 3, transcript variant X1
sodium/calcium exchanger 3, transcript variant X2
sodium/calcium exchanger 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X7
leucine-rich repeat-containing protein 15 isoform X3
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X6
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X4
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X5
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X3
leucine-rich repeat-containing G-protein coupled receptor 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
insulin-like growth factor-binding protein complex acid labile subunit isoform X1
insulin-like growth factor-binding protein complex acid labile subunit isoform X2
polyribonucleotide nucleotidyltransferase 1, mitochondrial
complex I intermediate-associated protein 30, mitochondrial
probable cardiolipin synthase (CMP-forming)
LOW QUALITY PROTEIN: probable cardiolipin synthase (CMP-forming)
probable phospholipid hydroperoxide glutathione peroxidase, transcript variant X1
probable phospholipid hydroperoxide glutathione peroxidase, transcript variant X2
probable phospholipid hydroperoxide glutathione peroxidase
putative epidermal cell surface receptor, transcript variant X2
putative epidermal cell surface receptor, transcript variant X1
putative epidermal cell surface receptor isoform X1
putative epidermal cell surface receptor isoform X2
uncharacterized LOC125385124, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC125385124, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC100648318, transcript variant X3
uncharacterized LOC100648318, transcript variant X2
uncharacterized LOC100648318, transcript variant X1
uncharacterized protein LOC100648318 isoform X3
uncharacterized protein LOC100648318 isoform X2
uncharacterized protein LOC100648318 isoform X1
baculoviral IAP repeat-containing protein 6, transcript variant X2
baculoviral IAP repeat-containing protein 6, transcript variant X1
baculoviral IAP repeat-containing protein 6 isoform X2
baculoviral IAP repeat-containing protein 6 isoform X1
39S ribosomal protein L11, mitochondrial, transcript variant X2
39S ribosomal protein L11, mitochondrial, transcript variant X1
39S ribosomal protein L11, mitochondrial
RING-type E3 ubiquitin-protein ligase PPIL2
X-box-binding protein 1, transcript variant X1
uncharacterized protein LOC100647771 isoform X1
X-box-binding protein 1, transcript variant X2
centrosomal and chromosomal factor, transcript variant X1
centrosomal and chromosomal factor, transcript variant X2
centrosomal and chromosomal factor, transcript variant X3
ribonuclease P protein subunit p14, transcript variant X2
ribonuclease P protein subunit p14, transcript variant X1
mitochondrial intermembrane space import and assembly protein 40-B
synaptosomal-associated protein 25, transcript variant X4
synaptosomal-associated protein 25, transcript variant X6
synaptosomal-associated protein 25, transcript variant X9
synaptosomal-associated protein 25, transcript variant X5
synaptosomal-associated protein 25, transcript variant X3
synaptosomal-associated protein 25, transcript variant X2
synaptosomal-associated protein 25, transcript variant X8
synaptosomal-associated protein 25, transcript variant X1
synaptosomal-associated protein 25, transcript variant X7
synaptosomal-associated protein 25, transcript variant X10
synaptosomal-associated protein 25 isoform X4
synaptosomal-associated protein 25 isoform X3
synaptosomal-associated protein 25 isoform X1
synaptosomal-associated protein 25 isoform X6
synaptosomal-associated protein 25 isoform X5
synaptosomal-associated protein 25 isoform X2
pre-mRNA-processing factor 39, transcript variant X1
pre-mRNA-processing factor 39, transcript variant X2
pre-mRNA-processing factor 39 isoform X2
pre-mRNA-processing factor 39 isoform X1
uncharacterized LOC105665735, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
uncharacterized LOC105665735, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
uncharacterized protein LOC105665735 isoform X1
uncharacterized protein LOC105665735 isoform X2
zinc finger protein 91, transcript variant X3
zinc finger protein 91, transcript variant X1
zinc finger protein 91, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ester hydrolase C11orf54 homolog, transcript variant X2
ester hydrolase C11orf54 homolog, transcript variant X1
ester hydrolase C11orf54 homolog isoform X2
ester hydrolase C11orf54 homolog isoform X1
receptor-type guanylate cyclase gcy-14, transcript variant X2
receptor-type guanylate cyclase gcy-14, transcript variant X3
receptor-type guanylate cyclase gcy-14, transcript variant X4
receptor-type guanylate cyclase gcy-14, transcript variant X5
receptor-type guanylate cyclase gcy-14 isoform X3
receptor-type guanylate cyclase gcy-14, transcript variant X1
receptor-type guanylate cyclase gcy-19 isoform X1
receptor-type guanylate cyclase gcy-19 isoform X2
receptor-type guanylate cyclase gcy-14, transcript variant X6
receptor-type guanylate cyclase gcy-14 isoform X4
ankyrin repeat and zinc finger domain-containing protein 1, transcript variant X1
ankyrin repeat and zinc finger domain-containing protein 1, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1 isoform X1
ankyrin repeat and zinc finger domain-containing protein 1 isoform X2
kinesin-like protein KIF21A, transcript variant X2
kinesin-like protein KIF21A, transcript variant X1
bifunctional arginine demethylase and lysyl-hydroxylase PSR
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 2
cilia- and flagella-associated protein 57
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X3
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X4
facilitated trehalose transporter Tret1-2 homolog, transcript variant X5
facilitated trehalose transporter Tret1-2 homolog isoform X2
uncharacterized LOC105665734, transcript variant X5
uncharacterized LOC105665734, transcript variant X4
uncharacterized LOC105665734, transcript variant X1
uncharacterized LOC105665734, transcript variant X3
uncharacterized LOC105665734, transcript variant X2
uncharacterized LOC100647179, transcript variant X4
uncharacterized LOC100647179, transcript variant X3
uncharacterized LOC100647179, transcript variant X2
uncharacterized LOC100647179, transcript variant X1
uncharacterized MFS-type transporter C09D4.1, transcript variant X1
uncharacterized MFS-type transporter C09D4.1, transcript variant X2
uncharacterized MFS-type transporter C09D4.1 isoform X1
uncharacterized MFS-type transporter C09D4.1 isoform X2
uncharacterized LOC100650481, transcript variant X4
uncharacterized LOC100650481, transcript variant X1
uncharacterized LOC100650481, transcript variant X5
uncharacterized LOC100650481, transcript variant X3
uncharacterized protein LOC100650481 isoform X3
uncharacterized protein LOC100650481 isoform X1
uncharacterized protein LOC100650481 isoform X4
uncharacterized protein LOC100650481 isoform X5
uncharacterized LOC100650481, transcript variant X2
uncharacterized protein LOC100650481 isoform X2
uncharacterized LOC100650481, transcript variant X6
uncharacterized protein LOC100650481 isoform X6
uncharacterized LOC100650481, transcript variant X7
uncharacterized LOC100650481, transcript variant X9
uncharacterized LOC100650481, transcript variant X8
uncharacterized protein LOC100650481 isoform X7
uncharacterized protein LOC100650481 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
vacuolar protein-sorting-associated protein 25, transcript variant X4
vacuolar protein-sorting-associated protein 25, transcript variant X1
vacuolar protein-sorting-associated protein 25, transcript variant X3
vacuolar protein-sorting-associated protein 25, transcript variant X5
vacuolar protein-sorting-associated protein 25, transcript variant X2
vacuolar protein-sorting-associated protein 25
cyclin-dependent kinases regulatory subunit
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1, transcript variant X2
protein arginine N-methyltransferase 1 isoform X1
protein arginine N-methyltransferase 1 isoform X2
AT-rich interactive domain-containing protein 4B
uncharacterized LOC100646377, transcript variant X1
uncharacterized LOC100646377, transcript variant X2
ubiquitin carboxyl-terminal hydrolase puf
transmembrane protein 245, transcript variant X1
transmembrane protein 245, transcript variant X2
translation initiation factor IF-2, mitochondrial, transcript variant X1
translation initiation factor IF-2, mitochondrial isoform X1
translation initiation factor IF-2, mitochondrial, transcript variant X3
translation initiation factor IF-2, mitochondrial, transcript variant X2
translation initiation factor IF-2, mitochondrial isoform X2
translation initiation factor IF-2, mitochondrial isoform X3
proline hydroxylase buaE, transcript variant X8
proline hydroxylase buaE, transcript variant X5
proline hydroxylase buaE, transcript variant X4
proline hydroxylase buaE, transcript variant X7
proline hydroxylase buaE, transcript variant X3
proline hydroxylase buaE, transcript variant X10
proline hydroxylase buaE, transcript variant X11
2-oxoglutarate-Fe(II) type oxidoreductase ppzD isoform X7
proline hydroxylase buaE, transcript variant X6
proline hydroxylase buaE, transcript variant X9
proline hydroxylase buaE, transcript variant X2
proline hydroxylase buaE, transcript variant X1
uncharacterized LOC110119324, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110119324, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC125385088, transcript variant X2
uncharacterized LOC125385088, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
homeobox protein SIX1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
homeobox protein SIX1, transcript variant X3
homeobox protein SIX1, transcript variant X1
homeobox protein SIX1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
ral GTPase-activating protein subunit alpha-1, transcript variant X4
ral GTPase-activating protein subunit alpha-1, transcript variant X9
ral GTPase-activating protein subunit alpha-1, transcript variant X10
ral GTPase-activating protein subunit alpha-1, transcript variant X1
ral GTPase-activating protein subunit alpha-1, transcript variant X3
ral GTPase-activating protein subunit alpha-1, transcript variant X5
ral GTPase-activating protein subunit alpha-1, transcript variant X6
ral GTPase-activating protein subunit alpha-1, transcript variant X2
ral GTPase-activating protein subunit alpha-1, transcript variant X8
ral GTPase-activating protein subunit alpha-1, transcript variant X7
ral GTPase-activating protein subunit alpha-1 isoform X1
ral GTPase-activating protein subunit alpha-1 isoform X3
ral GTPase-activating protein subunit alpha-1 isoform X4
ral GTPase-activating protein subunit alpha-1 isoform X5
ral GTPase-activating protein subunit alpha-1 isoform X6
ral GTPase-activating protein subunit alpha-1 isoform X2
ral GTPase-activating protein subunit alpha-1 isoform X7
ral GTPase-activating protein subunit alpha-1 isoform X8
ral GTPase-activating protein subunit alpha-1 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 134 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 142 samples with support for all annotated introns
kinesin-like protein Klp98A, transcript variant X2
kinesin-like protein Klp98A, transcript variant X1
myosin-I heavy chain, transcript variant X1
myosin-I heavy chain, transcript variant X2
balbiani ring protein 3, transcript variant X2
balbiani ring protein 3, transcript variant X3
balbiani ring protein 3, transcript variant X1
uncharacterized LOC125385103, transcript variant X1
uncharacterized LOC125385103, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X6
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X5
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ribosomal RNA processing protein 36 homolog
sodium/potassium-transporting ATPase subunit alpha, transcript variant X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X1
sodium/potassium-transporting ATPase subunit alpha, transcript variant X5
sodium/potassium-transporting ATPase subunit alpha, transcript variant X3
sodium/potassium-transporting ATPase subunit alpha, transcript variant X6
sodium/potassium-transporting ATPase subunit alpha, transcript variant X4
sodium/potassium-transporting ATPase subunit alpha isoform X2
sodium/potassium-transporting ATPase subunit alpha isoform X1
sodium/potassium-transporting ATPase subunit alpha isoform X5
sodium/potassium-transporting ATPase subunit alpha isoform X3
sodium/potassium-transporting ATPase subunit alpha isoform X6
sodium/potassium-transporting ATPase subunit alpha isoform X4
sodium/potassium-transporting ATPase subunit alpha, transcript variant X7
sodium/potassium-transporting ATPase subunit alpha isoform X7
NPC intracellular cholesterol transporter 2-like, transcript variant X2
NPC intracellular cholesterol transporter 2-like, transcript variant X1
NPC intracellular cholesterol transporter 2-like isoform X2
NPC intracellular cholesterol transporter 2-like isoform X1
estradiol 17-beta-dehydrogenase 2, transcript variant X2
estradiol 17-beta-dehydrogenase 2, transcript variant X1
estradiol 17-beta-dehydrogenase 2 isoform X2
estradiol 17-beta-dehydrogenase 2 isoform X1
28S ribosomal protein S18a, mitochondrial
ribosome-releasing factor 2, mitochondrial
transcription factor kayak, transcript variant X2
transcription factor kayak, transcript variant X1
transcription factor kayak, transcript variant X4
transcription factor kayak, transcript variant X3
uncharacterized LOC105665722, transcript variant X2
uncharacterized LOC105665722, transcript variant X3
uncharacterized LOC105665722, transcript variant X4
uncharacterized LOC105665722, transcript variant X1
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X10
nuclear receptor coactivator 7 isoform X9
nuclear receptor coactivator 7 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TLD domain-containing protein 2, transcript variant X8
nuclear receptor coactivator 7 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X2
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X3
nuclear receptor coactivator 7 isoform X1
nuclear receptor coactivator 7 isoform X4
nuclear receptor coactivator 7 isoform X2
oxidation resistance protein 1 isoform X6
oxidation resistance protein 1 isoform X7
oxidation resistance protein 1 isoform X5
nuclear receptor coactivator 7 isoform X3
TLD domain-containing protein 2, transcript variant X12
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2 isoform X11
uncharacterized LOC125385102, transcript variant X3
uncharacterized LOC125385102, transcript variant X2
uncharacterized LOC125385102, transcript variant X1
TLD domain-containing protein 2, transcript variant X13
TLD domain-containing protein 2 isoform X12
uncharacterized LOC125385112, transcript variant X2
uncharacterized LOC125385112, transcript variant X1
uncharacterized LOC105665721, transcript variant X2
uncharacterized LOC105665721, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X4
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X3
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X5
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X3
eukaryotic translation initiation factor 2A
mitochondrial import inner membrane translocase subunit TIM14
histone acetyltransferase type B catalytic subunit
V-type proton ATPase subunit C, transcript variant X1
V-type proton ATPase subunit C, transcript variant X3
V-type proton ATPase subunit C, transcript variant X2
V-type proton ATPase subunit C isoform X2
V-type proton ATPase subunit C isoform X1
membrane-bound transcription factor site-1 protease
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
general transcription factor 3C polypeptide 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC100651156, transcript variant X3
uncharacterized LOC100651156, transcript variant X1
uncharacterized LOC100651156, transcript variant X2
leucine-rich repeat-containing protein 49, transcript variant X2
leucine-rich repeat-containing protein 49, transcript variant X1
leucine-rich repeat-containing protein 49, transcript variant X3
leucine-rich repeat-containing protein 49 isoform X2
leucine-rich repeat-containing protein 49 isoform X1
leucine-rich repeat-containing protein 49 isoform X3
leucine-rich repeat-containing protein 49, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 106 samples with support for all annotated introns
leucine-rich repeat-containing protein 49 isoform X4
39S ribosomal protein L54, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 155 samples with support for all annotated introns
ribosome quality control complex subunit NEMF homolog, transcript variant X1
ribosome quality control complex subunit NEMF homolog isoform X1
ribosome quality control complex subunit NEMF homolog, transcript variant X2
ribosome quality control complex subunit NEMF homolog isoform X2
serine/threonine-protein kinase VRK1, transcript variant X1
serine/threonine-protein kinase VRK1, transcript variant X2
serine/threonine-protein kinase VRK1 isoform X1
serine/threonine-protein kinase VRK1 isoform X2
serine/threonine-protein kinase greatwall, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
serine/threonine-protein kinase greatwall, transcript variant X1
serine/threonine-protein kinase greatwall
protein grainyhead, transcript variant X2
protein grainyhead, transcript variant X1
protein grainyhead, transcript variant X4
uncharacterized protein LOC100643801 isoform X4
protein grainyhead, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulator of G-protein signaling 17, transcript variant X5
regulator of G-protein signaling 17, transcript variant X4
regulator of G-protein signaling 17, transcript variant X7
regulator of G-protein signaling 17, transcript variant X2
regulator of G-protein signaling 17, transcript variant X3
regulator of G-protein signaling 17, transcript variant X6
regulator of G-protein signaling 17, transcript variant X1
regulator of G-protein signaling 17 isoform X7
regulator of G-protein signaling 17 isoform X6
regulator of G-protein signaling 17 isoform X5
regulator of G-protein signaling 17 isoform X2
regulator of G-protein signaling 17 isoform X4
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X3
uncharacterized LOC100652113, transcript variant X10
uncharacterized LOC100652113, transcript variant X11
uncharacterized LOC100652113, transcript variant X5
uncharacterized LOC100652113, transcript variant X9
uncharacterized LOC100652113, transcript variant X1
uncharacterized LOC100652113, transcript variant X14
uncharacterized LOC100652113, transcript variant X6
uncharacterized LOC100652113, transcript variant X2
uncharacterized LOC100652113, transcript variant X3
uncharacterized LOC100652113, transcript variant X4
uncharacterized LOC100652113, transcript variant X8
uncharacterized LOC100652113, transcript variant X7
uncharacterized protein LOC100652113 isoform X1
uncharacterized protein LOC100652113 isoform X5
uncharacterized protein LOC100652113 isoform X2
uncharacterized LOC100652113, transcript variant X12
uncharacterized protein LOC100652113 isoform X3
uncharacterized LOC100652113, transcript variant X13
uncharacterized protein LOC100652113 isoform X4
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4
MATH and LRR domain-containing protein PFE0570w, transcript variant X4
MATH and LRR domain-containing protein PFE0570w, transcript variant X2
MATH and LRR domain-containing protein PFE0570w, transcript variant X8
MATH and LRR domain-containing protein PFE0570w, transcript variant X7
MATH and LRR domain-containing protein PFE0570w, transcript variant X1
MATH and LRR domain-containing protein PFE0570w, transcript variant X9
MATH and LRR domain-containing protein PFE0570w, transcript variant X3
MATH and LRR domain-containing protein PFE0570w, transcript variant X5
MATH and LRR domain-containing protein PFE0570w, transcript variant X6
MATH and LRR domain-containing protein PFE0570w isoform X1
MATH and LRR domain-containing protein PFE0570w isoform X2
uncharacterized LOC100644171, transcript variant X2
uncharacterized LOC100644171, transcript variant X1
adipocyte plasma membrane-associated protein
uncharacterized LOC105665719, transcript variant X2
uncharacterized LOC105665719, transcript variant X1
uncharacterized LOC105665719, transcript variant X3
uncharacterized protein LOC105665719 isoform X2
uncharacterized protein LOC105665719 isoform X1
uncharacterized protein LOC105665719 isoform X3
probable G-protein coupled receptor Mth-like 1, transcript variant X5
probable G-protein coupled receptor Mth-like 1, transcript variant X4
probable G-protein coupled receptor Mth-like 1, transcript variant X1
probable G-protein coupled receptor Mth-like 1, transcript variant X2
probable G-protein coupled receptor Mth-like 1, transcript variant X3
probable G-protein coupled receptor Mth-like 1 isoform X2
probable G-protein coupled receptor Mth-like 1 isoform X1
probable G-protein coupled receptor Mth-like 5, transcript variant X1
probable G-protein coupled receptor Mth-like 5, transcript variant X2
probable G-protein coupled receptor Mth-like 5
single-strand selective monofunctional uracil DNA glycosylase
probable tubulin polyglutamylase ttll-15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIP12, transcript variant X2
E3 ubiquitin-protein ligase TRIP12, transcript variant X6
E3 ubiquitin-protein ligase TRIP12, transcript variant X4
E3 ubiquitin-protein ligase TRIP12, transcript variant X5
E3 ubiquitin-protein ligase TRIP12, transcript variant X1
E3 ubiquitin-protein ligase TRIP12, transcript variant X7
E3 ubiquitin-protein ligase TRIP12, transcript variant X3
E3 ubiquitin-protein ligase TRIP12 isoform X3
E3 ubiquitin-protein ligase TRIP12 isoform X2
E3 ubiquitin-protein ligase TRIP12 isoform X1
zinc finger protein ZFP2, transcript variant X4
zinc finger protein ZFP2, transcript variant X3
zinc finger protein ZFP2, transcript variant X2
zinc finger protein ZFP2, transcript variant X1
zinc finger protein ZFP2, transcript variant X5
LOW QUALITY PROTEIN: uncharacterized protein LOC100649690
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X2
INO80 complex subunit D, transcript variant X4
INO80 complex subunit D, transcript variant X1
INO80 complex subunit D, transcript variant X2
INO80 complex subunit D, transcript variant X3
HSPB1-associated protein 1, transcript variant X2
HSPB1-associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
uridine diphosphate glucose pyrophosphatase NUDT14
beclin-1-like protein, transcript variant X1
beclin-1-like protein, transcript variant X2
homeobox protein homothorax, transcript variant X4
homeobox protein homothorax, transcript variant X3
homeobox protein homothorax, transcript variant X5
homeobox protein homothorax, transcript variant X2
homeobox protein homothorax, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
two pore potassium channel protein sup-9, transcript variant X1
two pore potassium channel protein sup-9, transcript variant X2
two pore potassium channel protein sup-9 isoform X1
two pore potassium channel protein sup-9 isoform X2
chromodomain-helicase-DNA-binding protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/arginine-rich splicing factor 4-like
uncharacterized LOC100647897, transcript variant X2
uncharacterized LOC100647897, transcript variant X1
uncharacterized LOC100647897, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein LOC100647897 isoform X1
uncharacterized LOC100647897, transcript variant X4
uncharacterized LOC100647897, transcript variant X5
uncharacterized protein LOC100647897 isoform X2
protein phosphatase 1B, transcript variant X4
protein phosphatase 1B, transcript variant X2
protein phosphatase 1B, transcript variant X1
protein phosphatase 1B, transcript variant X3
beclin 1-associated autophagy-related key regulator, transcript variant X2
beclin 1-associated autophagy-related key regulator, transcript variant X1
beclin 1-associated autophagy-related key regulator isoform X2
beclin 1-associated autophagy-related key regulator isoform X1
probable cleavage and polyadenylation specificity factor subunit 2, transcript variant X2
probable cleavage and polyadenylation specificity factor subunit 2, transcript variant X1
probable cleavage and polyadenylation specificity factor subunit 2
dynein axonemal heavy chain 7, transcript variant X2
dynein axonemal heavy chain 7, transcript variant X1
dynein axonemal heavy chain 7 isoform X1
dynein axonemal heavy chain 7 isoform X2
spliceosome-associated protein CWC27 homolog
uncharacterized LOC100649767, transcript variant X2
uncharacterized protein LOC100649767 isoform X2
uncharacterized LOC100649767, transcript variant X1
uncharacterized protein LOC100649767 isoform X1
muscle M-line assembly protein unc-89-like
uncharacterized LOC100644718, transcript variant X2
uncharacterized LOC100644718, transcript variant X1
uncharacterized LOC100644718, transcript variant X4
uncharacterized LOC100644718, transcript variant X3
uncharacterized protein LOC100644718 isoform X2
uncharacterized protein LOC100644718 isoform X1
uncharacterized protein LOC100644718 isoform X3
putative ferric-chelate reductase 1 homolog, transcript variant X2
putative ferric-chelate reductase 1 homolog, transcript variant X1
putative ferric-chelate reductase 1 homolog isoform X1
putative ferric-chelate reductase 1 homolog isoform X2
tripartite motif-containing protein 2, transcript variant X4
tripartite motif-containing protein 2, transcript variant X3
tripartite motif-containing protein 2, transcript variant X1
tripartite motif-containing protein 2, transcript variant X2
tripartite motif-containing protein 2, transcript variant X5
tripartite motif-containing protein 2 isoform X3
tripartite motif-containing protein 2 isoform X4
tripartite motif-containing protein 2 isoform X1
tripartite motif-containing protein 2 isoform X2
tripartite motif-containing protein 2 isoform X5
DNA polymerase iota, transcript variant X2
DNA polymerase iota, transcript variant X3
DNA polymerase iota, transcript variant X1
E3 SUMO-protein ligase PIAS2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
E3 SUMO-protein ligase PIAS2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E3 SUMO-protein ligase PIAS2, transcript variant X3
E3 SUMO-protein ligase PIAS2, transcript variant X7
E3 SUMO-protein ligase PIAS2, transcript variant X6
E3 SUMO-protein ligase PIAS2, transcript variant X8
E3 SUMO-protein ligase PIAS2, transcript variant X1
E3 SUMO-protein ligase PIAS2, transcript variant X10
E3 SUMO-protein ligase PIAS2, transcript variant X2
E3 SUMO-protein ligase PIAS2, transcript variant X9
acetylcholine receptor subunit beta-like 2, transcript variant X1
acetylcholine receptor subunit beta-like 2, transcript variant X2
acetylcholine receptor subunit beta-like 2 isoform X2
acetylcholine receptor subunit beta-like 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
26S proteasome non-ATPase regulatory subunit 9
tetratricopeptide repeat protein 30A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 109 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
tetratricopeptide repeat protein 30A isoform X4
tetratricopeptide repeat protein 30A isoform X3
tetratricopeptide repeat protein 30A isoform X2
tetratricopeptide repeat protein 30A isoform X1
DNA polymerase epsilon subunit 2, transcript variant X2
DNA polymerase epsilon subunit 2, transcript variant X3
DNA polymerase epsilon subunit 2, transcript variant X4
DNA polymerase epsilon subunit 2, transcript variant X1
DNA polymerase epsilon subunit 2 isoform X1
DNA polymerase epsilon subunit 2 isoform X2
cyclin-dependent kinase-like 4, transcript variant X2
cyclin-dependent kinase-like 4, transcript variant X5
cyclin-dependent kinase-like 4, transcript variant X1
cyclin-dependent kinase-like 4, transcript variant X4
cyclin-dependent kinase-like 4, transcript variant X3
cyclin-dependent kinase-like 4 isoform X1
cyclin-dependent kinase-like 4 isoform X4
cyclin-dependent kinase-like 4 isoform X3
cyclin-dependent kinase-like 4 isoform X2
uncharacterized LOC105666769, transcript variant X2
uncharacterized LOC105666769, transcript variant X1
uncharacterized LOC105666769, transcript variant X3